Investigating the ocular toxicity potential and therapeutic efficiency of
Draize
HET-CAM
MTT
brinzolamide
glaucoma
in situ gel nanoemulsion
Journal
Toxicology research
ISSN: 2045-452X
Titre abrégé: Toxicol Res (Camb)
Pays: England
ID NLM: 101587950
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
03
03
2020
revised:
27
06
2020
accepted:
27
07
2020
entrez:
9
9
2020
pubmed:
10
9
2020
medline:
10
9
2020
Statut:
epublish
Résumé
Glaucoma is an ocular disease i.e. more common in older adults with elevated intraocular pressure and a serious threat to vision if it is not controlled. Due to the limitations regarding the conventional form of brinzolamide (Azopt®), two optimum formulations of
Identifiants
pubmed: 32905229
doi: 10.1093/toxres/tfaa066
pii: tfaa066
pmc: PMC7467242
doi:
Types de publication
Journal Article
Langues
eng
Pagination
578-587Informations de copyright
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Références
Drug Deliv. 2016 Nov;23(9):3712-3723
pubmed: 27689408
J Pharmacol Toxicol Methods. 2010 Mar-Apr;61(2):136-45
pubmed: 20096797
Am J Ophthalmol. 2011 Oct;152(4):515-22
pubmed: 21961848
Trends Pharmacol Sci. 2004 May;25(5):238-41
pubmed: 15120486
Int J Occup Saf Ergon. 1999;5(1):43-57
pubmed: 10602638
J Endod. 2003 Oct;29(10):654-7
pubmed: 14606789
Nanomaterials (Basel). 2018 Jan 19;8(1):
pubmed: 29351260
Int J Pharm. 2011 Jul 15;413(1-2):202-10
pubmed: 21540093
J Ocul Pharmacol Ther. 2012 Oct;28(5):484-96
pubmed: 22694593
Pharm Dev Technol. 2019 Jun;24(5):600-606
pubmed: 30472913
Asian J Pharm Sci. 2019 Jan;14(1):1-15
pubmed: 32104434
Invest Ophthalmol Vis Sci. 2003 Sep;44(9):3783-9
pubmed: 12939292
Drug Discov Today. 2017 Apr;22(4):638-651
pubmed: 28017837
J Pharmacol Toxicol Methods. 2019 Mar - Apr;96:9-14
pubmed: 30552958
Adv Drug Deliv Rev. 2007 Sep 30;59(11):1162-76
pubmed: 17870202
Nanotoxicology. 2016 Sep;10(7):836-60
pubmed: 27027670
3 Biotech. 2015 Apr;5(2):123-127
pubmed: 28324579
Adv Drug Deliv Rev. 2006 Nov 15;58(11):1131-5
pubmed: 17097758
Curr Opin Ophthalmol. 2007 Mar;18(2):110-4
pubmed: 17301611
Colloids Surf B Biointerfaces. 2015 Apr 1;128:322-330
pubmed: 25707750
Acta Vet Hung. 2010 Sep;58(3):369-77
pubmed: 20713327
Drug Dev Ind Pharm. 2014 Sep;40(9):1223-32
pubmed: 23837522
J Ocul Pharmacol Ther. 2003 Oct;19(5):397-404
pubmed: 14583132
Curr Opin Allergy Clin Immunol. 2006 Oct;6(5):367-72
pubmed: 16954791
Toxicology. 2015 Jan 2;327:32-46
pubmed: 25445805
Am J Ophthalmol. 1998 Sep;126(3):400-8
pubmed: 9744373
Toxicol Res (Camb). 2019 Mar 21;8(4):522-530
pubmed: 31367335
Drug Dev Ind Pharm. 2010 Nov;36(11):1330-9
pubmed: 20545523
Expert Opin Drug Deliv. 2012 Apr;9(4):383-402
pubmed: 22432690
Drug Deliv Transl Res. 2020 Apr;10(2):529-547
pubmed: 31820300
Drug Dev Ind Pharm. 2002 Apr;28(4):353-69
pubmed: 12056529